BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35923575)

  • 1. Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers.
    Guo N; Chen Y; Jing Z; Liu S; Su J; Li R; Duan X; Chen Z; Chen P; Yin R; Li S; Tang J
    Front Bioeng Biotechnol; 2022; 10():909388. PubMed ID: 35923575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients.
    Xie F; Zhang Y; Mao X; Zheng X; Han-Zhang H; Ye J; Zhao R; Zhang X; Sun J
    Lung Cancer; 2018 Jul; 121():54-60. PubMed ID: 29858028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
    Chen B; Zhang G; Lai J; Xiao W; Li X; Li C; Mok H; Li K; Wang Y; Cao L; Jia M; Ren C; Wen L; Wei G; Lin J; Li Y; Zhang Y; Chen X; Wu X; Zhang H; Li M; Liu J; Balch CM; Liao N
    EBioMedicine; 2021 Sep; 71():103542. PubMed ID: 34454403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Landscape of Metastatic Lymph Nodes and Primary Tumors in Non-Small-Cell Lung Cancer.
    Chen B; Li R; Zhang J; Xu L; Jiang F
    Pathol Oncol Res; 2022; 28():1610020. PubMed ID: 35783357
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancer.
    Li J; Yi H; Liu Z; Zhang H; Zhang D; Yue W; Jia H; Xu S; Li B
    Exp Ther Med; 2015 Feb; 9(2):389-394. PubMed ID: 25574203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage IA non-small cell lung cancer.
    Ding N; Mao Y; Gao S; Xue Q; Wang D; Zhao J; Gao Y; Huang J; Shao K; Feng F; Zhao Y; Yuan L
    J Thorac Dis; 2018 Jul; 10(7):4061-4068. PubMed ID: 30174849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients.
    Xi L; Coello MC; Litle VR; Raja S; Gooding WE; Yousem SA; El-Hefnawy T; Landreneau RJ; Luketich JD; Godfrey TE
    Clin Cancer Res; 2006 Apr; 12(8):2484-91. PubMed ID: 16638856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial).
    Hu L; Liang G; Yuliang W; Bingjing Z; Xiangdong Z; Rufu X
    Trials; 2013 Feb; 14():45. PubMed ID: 23413951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Study of Genetic Profiles of Key Oncogenesis-Related Genes between Primary Lesions and Matched Lymph Nodes Metastasis in Lung Cancer.
    Chen Y; Mao B; Peng X; Zhou Y; Xia K; Guo H; Jiang H; Wang G; Zhuang W
    J Cancer; 2019; 10(7):1642-1650. PubMed ID: 31205520
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
    Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
    J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value on SUV-derived parameters assessed on
    Liao X; Liu M; Li S; Huang W; Guo C; Liu J; Xiong Y; Zhang J; Fan Y; Wang R
    BMC Med Imaging; 2023 Apr; 23(1):49. PubMed ID: 37020286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.
    Bi MM; Shang B; Wang Z; Chen G
    Thorac Cancer; 2017 Nov; 8(6):634-641. PubMed ID: 28925100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of patterns of nodal metastases in BRAF mutant lung cancer.
    McEvoy SH; Halpenny DF; Viteri-Jusué A; Hayes SA; Plodkowski AJ; Riely GJ; Ginsberg MS
    Lung Cancer; 2017 Jun; 108():62-65. PubMed ID: 28625649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
    Ahrendt SA; Yang SC; Wu L; Roig CM; Russell P; Westra WH; Jen J; Brock MV; Heitmiller RF; Sidransky D
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):466-73; discussion 473-4. PubMed ID: 11882817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study.
    Moulla Y; Gradistanac T; Wittekind C; Eichfeld U; Gockel I; Dietrich A
    J Cardiothorac Surg; 2019 Jan; 14(1):11. PubMed ID: 30651112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing and Origins of Local and Distant Metastases in Lung Cancer.
    Tang WF; Wu M; Bao H; Xu Y; Lin JS; Liang Y; Zhang Y; Chu XP; Qiu ZB; Su J; Zhang JT; Zhang C; Xu FP; Chen JH; Fu R; Chen Y; Yang T; Chen QK; Wu TT; Wu X; Shao Y; Zheng JT; Xie Z; Lv ZY; Dong S; Wu YL; Zhong WZ
    J Thorac Oncol; 2021 Jul; 16(7):1136-1148. PubMed ID: 33722707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.
    Park S; Holmes-Tisch AJ; Cho EY; Shim YM; Kim J; Kim HS; Lee J; Park YH; Ahn JS; Park K; Jänne PA; Ahn MJ
    J Thorac Oncol; 2009 Jul; 4(7):809-15. PubMed ID: 19487967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.